Home / Tocilizumab / Japan
JP ATC L04AC07 · updated 2 Nov 2026
Tocilizumab shortage in Japan
Is there a Tocilizumab shortage in Japan?
Yes. As of 2 Nov 2026, 3 Tocilizumab products are reported short in Japan, the first since 19 Jun 2026. No return date has been given. Main reason: increased demand.
Also short in Canada, Italy, Austria, Czechia. All countries.
Affected products in Japan
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | トシリズマブBS点滴静注200mg「CT」 limited | セルトリオン・ヘルスケア・ジャパン | 19 Jun 2026 | not given | Other |
| JP | トシリズマブBS点滴静注200mg「MA」 limited | Mochida | 6 Oct 2026 | not given | Increased demand |
| JP | トシリズマブBS点滴静注400mg「MA」 limited | Mochida | 6 Oct 2026 | not given | Increased demand |
Source
MHLW (Ministry of Health, Labour and Welfare), supply status of prescription medicines. Official list. Prescription products under limited shipment or supply suspension (delistings excluded); one row per product.